How Antimicrobial Resistance Surveillance Strengthens Nigeria’s Infection Control

Antimicrobial Resistance Surveillance

Antimicrobial resistance is increasingly threatening Nigeria’s healthcare system, making previously treatable infections harder to manage. A key strategy to combat this challenge is antimicrobial resistance surveillance, which allows healthcare professionals to track resistance patterns, inform treatment decisions, and implement effective infection control measures.

With Nigeria’s growing population and high antibiotic use, integrating surveillance into infection prevention strategies is crucial to protect patients and communities from the spread of resistant pathogens.

What Is Antimicrobial Resistance Surveillance?

Antimicrobial resistance surveillance is the systematic collection, analysis, and interpretation of data on resistant infections. It helps identify new resistance trends, monitor outbreaks, and support evidence- based interventions.

By embedding antimicrobial resistance surveillance within hospitals and public health systems, Nigeria can reduce infection rates, optimize antibiotic use, and save lives.

The Role of WHO Antimicrobial Resistance Surveillance

The WHO antimicrobial resistance surveillance framework provides countries like Nigeria with a standardized approach to collecting and reporting AMR data. It enables:

  • Early detection of resistant pathogens
  • Coordinated responses across healthcare facilities
  • Benchmarking against international standards

By following WHO guidelines, Nigerian health authorities can strengthen infection control practices and align with global AMR prevention efforts.

Key Insights from the Antimicrobial Resistance Global Report on Surveillance

The antimicrobial resistance global report on surveillance highlights worldwide AMR trends and lessons for national programs. Nigeria can benefit from these insights to prioritize resources, plan interventions, and enhance laboratory networks.

Focus AreaObservation from Global ReportImplication for Nigeria
Hospital-acquired infectionsMDR pathogens rising globallyStrengthen hygiene and isolation protocols
Antibiotic usageOveruse linked to resistanceImplement stewardship programs nationwide
Laboratory capacityLimited diagnostic infrastructureInvest in molecular labs for early detection
Public awarenessCommunity engagement reduces misuseLaunch nationwide AMR education campaigns

The antimicrobial resistance global report on surveillance emphasizes a multi-sectoral approach, which Nigeria can adopt to integrate public health, veterinary, and environmental data in AMR monitoring.

How Surveillance Supports Infection Control

  1. Early Detection and Containment – Surveillance identifies resistant infections before they become outbreaks.
  2. Informed Antibiotic Prescribing – Data guides clinicians in choosing effective treatments, reducing inappropriate use.
  3. Evidence-based Policy Making – National and state health policies can be shaped by real-time AMR data.
  4. Community Education and Awareness – Surveillance findings help design public campaigns that reduce misuse of antibiotics.

By leveraging antimicrobial resistance surveillance, Nigeria can improve both hospital-level infection control and community-level prevention measures.

Conclusion

In Nigeria, integrating antimicrobial resistance surveillance into healthcare systems is vital to controlling resistant infections. Using insights from WHO antimicrobial resistance surveillance and the antimicrobial resistance global report on surveillance, Nigeria can build a proactive AMR monitoring network that safeguards public health.

Investing in laboratories, training healthcare workers, and raising public awareness ensures a future where resistant infections are detected early, treated effectively, and prevented from spreading.

Scroll to Top
akinsete-omobosola-1004-240x240-29843

Dr. Omobosola Akinsete is a dedicated physician and a key member of the Nigerian Antimicrobial Stewardship Taskforce. She has been an internal medicine and adult Infectious Disease physician in the United States of America for 30  years . She graduated from Medical school at the University of Lagos, and has a masters in Public Health from Johns Hopkins school of Public Health. 

She did her Internal Medicine training at a Brown University hospital and her fellowship in Infectious Diseases  at the University of Minnesota where she is an associate professor. She has worked with the National Institutes of Health and Howard University a a coordinator for the Human Genome Project among other projects, she is a frequent public speaker and contributor to different types of media. She loves to advocate for healthcare in minority populations. She  has a lot of experience with  patients and health care providers on antimicrobial stewardship in her institution  HealthPartners in Minnesota U.S.A. Her expertise in the field of Infectious diseases and antimicrobial stewardship and her passion to improve health care in her home country will contribute significantly to the fight against antimicrobial resistance in Nigeria. Dr. Akinsete’s work with the taskforce focuses on leadership of the taskforce as chairperson and national coordinator, working closely with NCDC leadership, the Nigerian Federal Ministry of Health, stakeholders, and funding partners, and helping with capacity building of standardized antimicrobial stewardship and infectious disease educational programs. She will also use her expertise to guide providers and HealthCare institutions  on the ground . Her commitment to improving antimicrobial use and patient safety is invaluable to the nation’s public health efforts.